---
figid: PMC5350330__MI2017-6893560.006
figtitle: AM966 reduces pulmonary microvascular cell barrier integrity through LPA1/GA12/13-mediated
  phosphorylation of MLC and VE-cadherin
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC5350330
filename: MI2017-6893560.006.jpg
figlink: /pmc/articles/PMC5350330/figure/fig6/
number: F6
caption: AM966 reduces pulmonary microvascular cell barrier integrity through LPA1/Gα12/13-mediated
  phosphorylation of MLC and VE-cadherin. AM966 is ligated to LPA1 and triggers RhoA/Rho
  kinase pathway, thereby increasing MLC phosphorylation and cytoskeletal rearrangement.
  AM966 induces phosphorylation of VE-cadherin. Therefore, AM966 increases lung endothelial
  permeability.
papertitle: AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung
  Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway
  and Phosphorylation of VE-Cadherin.
reftext: Junting Cai, et al. Mediators Inflamm. 2017;2017:6893560.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9549956
figid_alias: PMC5350330__F6
figtype: Figure
redirect_from: /figures/PMC5350330__F6
ndex: 9532cfdc-deea-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5350330__MI2017-6893560.006.html
  '@type': Dataset
  description: AM966 reduces pulmonary microvascular cell barrier integrity through
    LPA1/Gα12/13-mediated phosphorylation of MLC and VE-cadherin. AM966 is ligated
    to LPA1 and triggers RhoA/Rho kinase pathway, thereby increasing MLC phosphorylation
    and cytoskeletal rearrangement. AM966 induces phosphorylation of VE-cadherin.
    Therefore, AM966 increases lung endothelial permeability.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - cta
  - Rho1
  - sqh
  - Mlc1
  - Mlc2
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
---
